Redacted Justification and Approval for Other Than Full and Open Competition Sequencing System for HIV-1 Genotype Testing
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- HT942626PE042
- Agency
-
Defense Health Agency
Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HT942626PE042
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Silver Spring, Maryland 20910, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency has awarded a sole-source follow-on contract to Vela Diagnostics for HIV-1 genotype sequencing equipment, kits, consumables, and maintenance services under contract HT942626PE042, with a total estimated value of $2,035,407.89.
Vela Diagnostics is the sole source because it is the only manufacturer of the Sentosa SQ Next Generation Sequencing system currently FDA-approved for clinical HIV-1 genotype assay testing. The Walter Reed Army Institute of Research (WRAIR) HIV Diagnostics and Reference Lab requires this specific FDA-approved instrument and reagents to perform genotype testing for monitoring drug resistance mutations in infected soldiers and beneficiaries, operating under College of American Pathologist accreditation standards. Competing sequencing platforms have been withdrawn from the marketplace or are Research Use Only products unsuitable for clinical diagnostic reporting.
The base period runs from September 30, 2026 through September 29, 2027 at $383,378.38 firm fixed price, with four option years valued at $394,879.73 to $431,495.74. Base year funding is Operations and Maintenance. The contracting officer determined the pricing fair and reasonable based on prior procurement history with Vela Diagnostics under contract W81XWH21P0202 (valued at $1,439,264.40 for 2021–2026). Procurement authority is 41 U.S.C. 1901 and FAR 12.201-1 for simplified procedures. The award date was September 18, 2026.
Notice text
The attached document is the Redacted Justification and Approval for the Other than Full anbd Open Competition of theSequencing System for HIV-1 Testing for WRAIR.
Awarded contract HT942626PE042 to unknown vendor for unknown amount on 2026-09-18.
Files
| File | Type | Posted |
|---|---|---|
| A.02. DHA JA FAR Part 13.5- RFO reference changes 7.30 - redacted HT942626PE042.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent DNA Synthesizer | — | No set-aside | |
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| 7A21--Siemens UniPOC Licenses and Service | VA Technology Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity